Optiver Holding
RCKT icon

Optiver Holding’s Rocket Pharmaceuticals RCKT Stock Holding History

Optiver Holding’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.39K Sell
1,868
-10,616
-85% -$35.3K ﹤0.01% 1892
2026
Q1 		$44.7K Buy
12,484
+10,659
+584% +$42.4K ﹤0.01% 981
2025
Q4 		$6.41K Buy
1,825
+745
+69% +$2.55K ﹤0.01% 1264
2025
Q3 		$3.52K Buy
+1,080
New +$3.4K ﹤0.01% 2066

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Optiver Holding's RCKT Position: Q2 2026 in Review

Optiver Holding reduced its Rocket Pharmaceuticals (RCKT) stake by 85% in Q2 2026, selling an estimated $35.3K and leaving 1,868 shares worth $6.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Optiver Holding first reported a position in RCKT in Q3 2025 and has held it in 4 quarters since. The position peaked at $44.7K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Optiver Holding held 1,868 shares of Rocket Pharmaceuticals worth $6.39K as of Q2 2026.
  • Optiver Holding sold 10,616 Rocket Pharmaceuticals shares in Q2 2026, an estimated $35.3K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1892 holding.
  • Optiver Holding first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Rocket Pharmaceuticals position peaked at $44.7K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.